Abstract
Peroxynitrite (ONOO−) is critically involved in the pathogenesis of cardiovascular diseases. Reaction with glutathione (GSH) was proposed to be a major detoxification pathway of ONOO− in the biological system. This study was undertaken to determine if chemically elevated intracellular GSH affords protection against ONOO−-mediated toxicity in vascular cells. Incubation of aortic smooth muscle A10 cells with 3H-1,2-dithiole-3-thione (D3T) led to a concentration- and time-dependent elevation of cellular GSH. Treatment of the cells with D3T also augmented protein and gene expression of γ-glutamylcysteine ligase. To examine the effects of D3T-induced GSH on ONOO−-mediated toxicity, we pretreated A10 cells with D3T and then exposed them to either authentic ONOO− or the ONOO− generator, 3-morpholinosydnonimine. We observed that D3T pretreatment of A10 cells resulted in a significant protection against ONOO− cytotoxicity. Conversely, depletion of cellular GSH by buthionine sulfoximine (BSO) caused a marked potentiation of ONOO− cytotoxicity. To further demonstrate the causal involvement of GSH induction in D3T cytoprotection, we cotreated A10 cells with BSO to abolish D3T-induced GSH elevation. BSO cotreatment was found to greatly reverse the protective effects of D3T on ONOO−-elicited cytotoxicity. Taken together, our results demonstrate that upregulating GSH biosynthesis by D3T results in a marked protection against ONOO−-induced toxicity in vascular cells.
Similar content being viewed by others
References
American Heart Association (2003). Heart Disease and Stroke Statistics—2003 Update. http://www.americanheart.com
Ross, R. (1999). Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340:115–126.
Wattanapitayakul, S.K. and Bauer, J.A. (2000). Oxidative pathways in cardiovascular diseases: roles, mechanisms, and therapeutic implications. Pharmacol. Ther. 89:187–206.
Steinberg, D. (2002). Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat. Med. 8:1211–1217.
Kojda, G. and Harrison, D. (1999). Interaction between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc. Res. 43:562–571.
Milstein, S. and Katusic, Z (1999). Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem. Biophys. Res. Commun. 263:681–684.
Ronson, R.S., Nakamura, M., and Vinten-Johansen, J. (1999). The cardiovascular effects and implications of peroxynitrite. Cardiovasc. Res. 44:47–59.
Beckman, J.S., Beckman, T.W., Chen, I., Marshall, P.A., and Freeman, B.A. (1990). Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87:1620–1624.
Beckman, J.S. and Koppenol, W.H. (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271:C1424–1437.
Wang, P. and Zweier, J.L. (1996). Measurement of nitric oxide and peroxynitrite generation in the postischemic heart: evidence for peroxynitrite-mediated reperfusion injury. J. Bio.. Chem. 271:29223–29230.
Zweier, J.L. Fertmann, J., and Wei, G. (2001). Nitric oxide and peroxynitrite in postischemic myocardium. Antioxid. Redox Signal. 3:11–22.
Mateo, A. O. and de Artinano, M.A. (2000). Nitric oxide reactivity and mechanisms involved in its biological effects. Pharmacol. Res. 42:421–427.
Cai, L. and Kang Y.J. (2001). Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc. Toxicol. 1:181–193.
Szabo, C. (2003). Multiple pathways of peroxynitrite cytotoxicity. Toxicol. Lett. 140–141:105–112.
Bloodsworth, A., O'Donnell, V. B., and Freeman, B.A. (2000) Nitric oxide regulation of free radical- and enzyme-mediated lipid and lipoprotein oxidation. Arterioscler. Thromb. Vasc. Biol. 20:1707–1715.
Cai, L., Klein, J.B., and Kang, Y.J. (2000). Metallothionein inhibits peroxynitrite-induced DNA and lipoprotein damage. J. Biol. Chem. 275:38957–38960.
Carr, A.C., McCall, M.R., and Frei, B. (2000). Oxidation of LDL by myeloperoxidase and reactive nitrogenspecies: reaction pathways and antioxidant protection. Arterioscler. Thromb. Vasc. Biol. 20:1716–1723.
Patel, R.P., Moellering, D., Murphy-Ullrich, J., Jo, H., Beckman, J.S., and Darley-Usmar, V.M. (2000). Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radic. Biol. Med. 28:1780–1794.
Escargueil-Blanc, I., Meilhac, O., Pieraggi, M.T., Arnal, J.F., Salvayre, R., and Negre-Salvayre, A. (1997). Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway. Prevention by aurintricarboxylic acid. Arterioscler. Thromb. Vasc. Biol. 17:331–339.
Chisolm, G.M. and Chai, Y. (2000). Regulation of cell growth by oxidized LDL. Free Radic. Biol. Med. 28:1697–1707.
Radi, R. Rodriguez, M., Castro, L. and Telleri, R. (1994). Inhibition of mitochondrial electron transported by peroxynitrite. Arch. Biochem. Biophys. 308:89–95.
Virag, L., Scott G.S., Antal-Szalmas, P., O'Connor, M., Ohshima, H., and Szabo, C. (1999). Requirement of intracellular calcium mobilization for peroxynitrite-induced poly(ADP-ribose) synthetase activation and cytotoxicity. Mol. Pharmacol. 56:824–833.
Walsh, K., Smith, R.C., and Kim, H.S. (2000). Vascular cell apoptosis in remodeling, restenosis, and plaque rupture. Circ. Res. 87:184–188.
Channon, K.M. (2002). Oxidative stress and coronary plaque stability. Arterioscler. Thromb. Vasc. Biol. 22:1751–1752.
Balazy, M., Kaminski, P.M., Mao, K, Tan, J., and Wolin, M.S. (1998). S-nitroglutathione: a product of the reaction between peroxynitrite and glutathione that generates nitric oxide. J. Biol. Chem. 273:32009–32015.
Lizasoain, I., Moro, M.A., Knowles, R.G., Darley-Usmar, V., and Moncada, S. (1996). Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem. J. 314:877–880.
Knight, T.R., Ho, Y.S., Farhood, A. and Jaeschke, H. (2002). Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione. J. Pharmacol. Exp. Ther. 303:468–475.
Kensler, T.W., Curphey, T.J., Maxiutenko, Y., and Roebuck, B.D. (2000). Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins. Drugs Metabol. Drug Interact. 17:3–22.
Kwak, M.K., Egner, P.A., Dolan, P.M., Ramos-Gomez, M., Groopman, J.D., Itoh, K., et al. (2001). Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat. Res. 480–481:305–315.
Cao, Z. and Li, Y. (2002). Chemical induction of cellular antioxidants affords marked protection against injury in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 292:50–57.
Cao, Z., Hardej, D., Trombetta, L.D., Trush, M.A., and Li, Y. (2003). Induction of cellular glutathione and glutathione S-transferase by 3H-1,2-dithiole-3-thione in rat aortic smooth muscle A10 cells: protection against acrolein-induced toxicity. Atherosclerosis 166:291–301.
Peng, X. and Li, Y. (2002). Induction of cellular glutathione-linked enzymes and catalase by the unique chemoprotective agent, 3H-1,2-dithiole-3-thione in rat cardiomyocytes affords protection against oxidative cell injury. Pharmacol. Res. 45:491–497.
Hissin, P.J. and Hilf, R.A. (1976). Fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74:214–226.
Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
Halford, W.P., Falco, V.C., Gebhardt, B.M., and Carr, D.J. (1999). The inherent quantitative capacity of the reverse transcription-polymerase chain reaction. Anal. Biochem. 266:181–191.
Anderson, M.E. (1998). Glutathione: an overview of biosynthesis and modulation. Chem. Biol. Interact. 111–112:1–14.
Virag, L., Szabo, E., Gergely, P., and Szabo, C. (2003). Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol. Lett. 140–141:113–124.
Masumoto, H. and Sies, H. (1996). The reaction of ebselen with peroxynitrite. Chem. Res. Toxicol. 9:262–267.
Klotz, L.O. and Sies, H. (2003). Defenses against peroxynitrite: selenocompounds and flavonoids. Toxicol. Lett. 140–141:125–132.
Kwak, M.K., Itoh, K., Yamamoto, M., Sutter, T.R., and Kensler, T.W. (2001). Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1,2-dimethiole-3-thione. Mol. Med. 7:135–145.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cao, Z., Li, Y. Protecting against peroxynitrite-mediated cytotoxicity in vascular smooth muscle cells via upregulating endogenous glutathione biosynthesis by 3H-1,2-dithiole-3-thione. Cardiovasc Toxicol 4, 339–353 (2004). https://doi.org/10.1385/CT:4:4:339
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/CT:4:4:339